Approval · Notice of Compliance 32403 · 2023
ABRYSVO: Notice of Compliance 32403
Issued December 21, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32403
- Date
- December 21, 2023
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ABRYSVO | 02544040 | Marketed |
Medicinal ingredients
- RSV SUBGROUP A STABILIZED PREFUSION F PROTEIN 0.12 MG per ML
- RSV SUBGROUP B STABILIZED PREFUSION F PROTEIN 0.12 MG per ML